Interferons induce normal and aberrant retinoic-acid receptors type α in acute promyelocytic leukemia cells

Potentiation of the induction of retinoid-dependent differentiation markers

Maurizio Gianní, Stefania Zanotta, Mineko Terao, Alessandro Rambaldi, Enrico Garattini

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Treatment of the acute promyelocytic (APL) cell line NB4 with interferon α (IFNα), as well as IFNβ and γ, results in an increased expression of the transcripts coding for retinoic-acid receptor type alpha (RARα) and the leukemia-specific retinoic acid receptor PML-RAR. Transcriptional induction of the RARα and PML-RAR mRNAs is rapid and it is parallelled by an increase in the corresponding proteins. Up-regulation of RARα and PML-RAR gene expression by IFNα is accompanied by a strong potentiation in the induction of 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase. However, IFNα does not have any effects on the retinoid-dependent regulation of the myeloid surface markers CD11b and CD33. The IFN-dependent increase in RARα levels and the enhancing effect of the cytokine an retinoid-dependent granulocytic markers expression may be a characteristic of PML-RAR positive cells, since the phenomena are not observed in HL-60 promyelocytes. Interferons as well as retinoids inhibit the growth of NB4 cells, although the 2 classes of compounds do not significantly interact in terms of anti-proliferative activity. These results suggest the possible use of combinations between IFNs and retinoic acid in the cyto-differentiating treatment of Apt. patients.

Original languageEnglish
Pages (from-to)75-83
Number of pages9
JournalInternational Journal of Cancer
Volume68
Issue number1
DOIs
Publication statusPublished - 1996

Fingerprint

Acute Promyelocytic Leukemia
Retinoic Acid Receptors
Differentiation Antigens
Retinoids
Interferons
Granulocyte Colony-Stimulating Factor Receptors
Granulocyte Precursor Cells
Messenger RNA
Tretinoin
Alkaline Phosphatase
Leukemia
Leukocytes
Up-Regulation
Cytokines
Gene Expression
Cell Line
Therapeutics
Growth
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{12df6a1a582845e0abfe0b914dd2fbb5,
title = "Interferons induce normal and aberrant retinoic-acid receptors type α in acute promyelocytic leukemia cells: Potentiation of the induction of retinoid-dependent differentiation markers",
abstract = "Treatment of the acute promyelocytic (APL) cell line NB4 with interferon α (IFNα), as well as IFNβ and γ, results in an increased expression of the transcripts coding for retinoic-acid receptor type alpha (RARα) and the leukemia-specific retinoic acid receptor PML-RAR. Transcriptional induction of the RARα and PML-RAR mRNAs is rapid and it is parallelled by an increase in the corresponding proteins. Up-regulation of RARα and PML-RAR gene expression by IFNα is accompanied by a strong potentiation in the induction of 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase. However, IFNα does not have any effects on the retinoid-dependent regulation of the myeloid surface markers CD11b and CD33. The IFN-dependent increase in RARα levels and the enhancing effect of the cytokine an retinoid-dependent granulocytic markers expression may be a characteristic of PML-RAR positive cells, since the phenomena are not observed in HL-60 promyelocytes. Interferons as well as retinoids inhibit the growth of NB4 cells, although the 2 classes of compounds do not significantly interact in terms of anti-proliferative activity. These results suggest the possible use of combinations between IFNs and retinoic acid in the cyto-differentiating treatment of Apt. patients.",
author = "Maurizio Giann{\'i} and Stefania Zanotta and Mineko Terao and Alessandro Rambaldi and Enrico Garattini",
year = "1996",
doi = "10.1002/(SICI)1097-0215(19960927)68:1<75::AID-IJC14>3.0.CO;2-5",
language = "English",
volume = "68",
pages = "75--83",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Interferons induce normal and aberrant retinoic-acid receptors type α in acute promyelocytic leukemia cells

T2 - Potentiation of the induction of retinoid-dependent differentiation markers

AU - Gianní, Maurizio

AU - Zanotta, Stefania

AU - Terao, Mineko

AU - Rambaldi, Alessandro

AU - Garattini, Enrico

PY - 1996

Y1 - 1996

N2 - Treatment of the acute promyelocytic (APL) cell line NB4 with interferon α (IFNα), as well as IFNβ and γ, results in an increased expression of the transcripts coding for retinoic-acid receptor type alpha (RARα) and the leukemia-specific retinoic acid receptor PML-RAR. Transcriptional induction of the RARα and PML-RAR mRNAs is rapid and it is parallelled by an increase in the corresponding proteins. Up-regulation of RARα and PML-RAR gene expression by IFNα is accompanied by a strong potentiation in the induction of 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase. However, IFNα does not have any effects on the retinoid-dependent regulation of the myeloid surface markers CD11b and CD33. The IFN-dependent increase in RARα levels and the enhancing effect of the cytokine an retinoid-dependent granulocytic markers expression may be a characteristic of PML-RAR positive cells, since the phenomena are not observed in HL-60 promyelocytes. Interferons as well as retinoids inhibit the growth of NB4 cells, although the 2 classes of compounds do not significantly interact in terms of anti-proliferative activity. These results suggest the possible use of combinations between IFNs and retinoic acid in the cyto-differentiating treatment of Apt. patients.

AB - Treatment of the acute promyelocytic (APL) cell line NB4 with interferon α (IFNα), as well as IFNβ and γ, results in an increased expression of the transcripts coding for retinoic-acid receptor type alpha (RARα) and the leukemia-specific retinoic acid receptor PML-RAR. Transcriptional induction of the RARα and PML-RAR mRNAs is rapid and it is parallelled by an increase in the corresponding proteins. Up-regulation of RARα and PML-RAR gene expression by IFNα is accompanied by a strong potentiation in the induction of 2 retinoid-dependent granulocytic markers, i.e., granulocyte-colony-stimulating factor receptor mRNA and leukocyte alkaline phosphatase. However, IFNα does not have any effects on the retinoid-dependent regulation of the myeloid surface markers CD11b and CD33. The IFN-dependent increase in RARα levels and the enhancing effect of the cytokine an retinoid-dependent granulocytic markers expression may be a characteristic of PML-RAR positive cells, since the phenomena are not observed in HL-60 promyelocytes. Interferons as well as retinoids inhibit the growth of NB4 cells, although the 2 classes of compounds do not significantly interact in terms of anti-proliferative activity. These results suggest the possible use of combinations between IFNs and retinoic acid in the cyto-differentiating treatment of Apt. patients.

UR - http://www.scopus.com/inward/record.url?scp=0029853751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029853751&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19960927)68:1<75::AID-IJC14>3.0.CO;2-5

DO - 10.1002/(SICI)1097-0215(19960927)68:1<75::AID-IJC14>3.0.CO;2-5

M3 - Article

VL - 68

SP - 75

EP - 83

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 1

ER -